Is there a target value for time in tight range for individuals with type 1 diabetes on MDI? Data from masked CGM.

Autor:	Ohno T; Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan., Tsujino D; Higashitotsuka Diabetes Internal Medicine Clinic, Yokohama, Kanagawa, Japan., Nishimura R; Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Jazyk:	angličtina
Zdroj:	Expert review of endocrinology & metabolism [Expert Rev Endocrinol Metab] 2024 Nov; Vol. 19 (6), pp. 507-512. Date of Electronic Publication: 2024 Sep 05.
DOI:	10.1080/17446651.2024.2400487
Abstrakt:	Objective: Time in Tight Range (TITR), defined as the percentage of time within the glucose range of 70 to 140 mg/dL, is anticipated to be challenging to maintain without causing hypoglycemia, especially in individuals with type 1 diabetes (T1D). This study aimed to investigate the TITR target value in individuals with T1D on multiple daily injections (MDI). Methods: The study included 101 individuals with T1D on MDI aged 15 to 75 who were hospitalized at Jikei University School of Medicine from September 2006 to November 2013 to conduct Continuous Glucose Monitoring (CGM). The cutoff values of TITR for predicting the attainment of GMI < 7.0%, and TBR < 4% were determined using Receiver Operating Characteristic (ROC) curves. Results: The TITR cutoff value was calculated to be 41% (sensitivity 81%, specificity 88%) and 40% (54%,72%) for predicting GMI < 7.0% and TBR < 4%. Conclusions: In individuals with T1D on MDI without devices capable of preventing hypoglycemia, it is recommended to target TITR at 40% to address the risk of increased hypoglycemia sufficiently.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu